HC Wainwright & Co. Maintains Buy on IGM Biosciences, Lowers Price Target to $59
HC Wainwright & Co. analyst Robert Burns maintains IGM Biosciences (NASDAQ:IGMS) with a Buy and lowers the price target from $76 to $59.
Why Did Truist Lower IGM Biosciences’ Price Target?
Truist has lowered the price target on IGM Biosciences Inc (NASDAQ:IGMS) to $74 from $80. The analyst Asthika Goonewardene says that the…
Morgan Stanley Maintains Equal-Weight on IGM Biosciences, Raises Price Target to $30
Morgan Stanley maintains IGM Biosciences (NASDAQ:IGMS) with a Equal-Weight and raises the price target from $25 to $30.
8 Stocks Halted In Tuesday’s Session
A circuit breaker is an automatic, temporary trading halt on certain securities when the underlying stock is experiencing times of high volatility. It is a measure put in place to help restore, and bring order to the markets.
Here are all the stocks halted on a circuit breaker today, according to Benzinga Pro.
Mid-Afternoon Market Update: Dow Surges 250 Points; NeoGenomics Shares Slide
U.S. stocks traded higher toward the end of trading, with the Dow jumping over 250 points on Tuesday.
Mid-Day Market Update: Crude Oil Down 2.5%; IGM Biosciences Shares Jump
U.S. stocks traded higher midway through trading, with the Dow jumping over 250 points on Tuesday.
36 Stocks Moving In Tuesday’s Mid-Day Session
Gainers
China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC) jumped 88.1% to $0.38 after declining 9% on Monday.
Mid-Morning Market Update: Markets Open Higher; McCormick Profit Beats Estimates
U.S. stocks opened on a strong note on Tuesday, with the Dow jumping around 350 points this morning.
IGM Biosciences Q4 EPS $(1.50) Beats $(1.54) Estimate
IGM Biosciences (NASDAQ:IGMS) reported quarterly losses of $(1.50) per share which beat the analyst consensus estimate of $(1.54) by 2.6 percent. This is a 89.87 percent decrease over losses of $(0.79) per share from the